Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Finished Goods (2016 - 2025)

STRATA Skin Sciences' Finished Goods history spans 13 years, with the latest figure at $213000.0 for Q4 2025.

  • On a quarterly basis, Finished Goods rose 3.9% to $213000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $213000.0, a 3.9% increase, with the full-year FY2025 number at $213000.0, up 3.9% from a year prior.
  • Finished Goods hit $213000.0 in Q4 2025 for STRATA Skin Sciences, up from $171000.0 in the prior quarter.
  • Over the last five years, Finished Goods for SSKN hit a ceiling of $877000.0 in Q1 2022 and a floor of $63000.0 in Q2 2025.
  • Historically, Finished Goods has averaged $308100.0 across 5 years, with a median of $281000.0 in 2021.
  • Biggest five-year swings in Finished Goods: skyrocketed 272.87% in 2023 and later crashed 80.85% in 2025.
  • Tracing SSKN's Finished Goods over 5 years: stood at $288000.0 in 2021, then tumbled by 55.21% to $129000.0 in 2022, then skyrocketed by 272.87% to $481000.0 in 2023, then plummeted by 57.38% to $205000.0 in 2024, then increased by 3.9% to $213000.0 in 2025.
  • Business Quant data shows Finished Goods for SSKN at $213000.0 in Q4 2025, $171000.0 in Q3 2025, and $63000.0 in Q2 2025.